🌊 Social🇮🇳 India
FDA Panel Backs First New mRNA Flu Vaccine in Years — What It Means for India
NPR·Friday, 19 June 2026
All nine members of a key US FDA advisory committee unanimously recommended Moderna's new mRNA influenza vaccine for adults aged 50 and over. This is the first vaccine the committee has recommended since 2023. The unanimous vote makes formal FDA approval very likely.
Why It Matters
India has a large population of adults over 50 who are vulnerable to influenza, and FDA approvals often shape what vaccines eventually get reviewed and adopted globally, including in India.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.